Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Global Forecast 2024-2030

Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Global Forecast 2024-2030


The Upstream Bioprocessing Market size was estimated at USD 10.70 billion in 2023 and expected to reach USD 12.09 billion in 2024, at a CAGR 13.54% to reach USD 26.03 billion by 2030.

Global Upstream Bioprocessing Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Upstream Bioprocessing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Upstream Bioprocessing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Upstream Bioprocessing Market, highlighting leading vendors and their innovative profiles. These include Boehringer Ingelheim International GmbH, Danaher Corporation, Eppendorf AG, Esco Micro Pte. Ltd, GE Healthcare, Getinge AB, High Purity New England, Lonza Group AG, Meissner Filtration Products, Inc.,, Merck KGaA, Rentschler Biopharma SE, Samsung BioLogics, Sartorius AG, Tornado Spectral Systems, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Upstream Bioprocessing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Bags & Containers
Bioreactors & Fermenters
Bioreactors Accessories
Cell Culture Products
Filters
Workflow
Cell Culture
Cell Separation
Media Preparation
Use Type
Multi-Use
Single-Use
Mode
In-House
Outsourced
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Upstream Bioprocessing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Upstream Bioprocessing Market?
3. What are the technology trends and regulatory frameworks in the Upstream Bioprocessing Market?
4. What is the market share of the leading vendors in the Upstream Bioprocessing Market?
5. Which modes and strategic moves are suitable for entering the Upstream Bioprocessing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Upstream Bioprocessing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for biotherapeutics
5.1.1.2. Growing implementation of process analytical technology (PAT)
5.1.1.3. Rapid adoption of single-use upstream bioprocessing
5.1.2. Restraints
5.1.2.1. High cost of establishing and maintaining an upstream processing unit
5.1.3. Opportunities
5.1.3.1. Increased acceptance and approvals of biosimilars
5.1.3.2. Rising application of upstream process in cell therapy, cell banking, drug discovery, and recombinant proteins
5.1.4. Challenges
5.1.4.1. Limitations to its capabilities related to standard upstream bioprocess monitoring
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Upstream Bioprocessing Market, by Product
6.1. Introduction
6.2. Bags & Containers
6.3. Bioreactors & Fermenters
6.4. Bioreactors Accessories
6.5. Cell Culture Products
6.6. Filters
7. Upstream Bioprocessing Market, by Workflow
7.1. Introduction
7.2. Cell Culture
7.3. Cell Separation
7.4. Media Preparation
8. Upstream Bioprocessing Market, by Use Type
8.1. Introduction
8.2. Multi-Use
8.3. Single-Use
9. Upstream Bioprocessing Market, by Mode
9.1. Introduction
9.2. In-House
9.3. Outsourced
10. Americas Upstream Bioprocessing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Upstream Bioprocessing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Upstream Bioprocessing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Boehringer Ingelheim International GmbH
14.1.2. Danaher Corporation
14.1.3. Eppendorf AG
14.1.4. Esco Micro Pte. Ltd
14.1.5. GE Healthcare
14.1.6. Getinge AB
14.1.7. High Purity New England
14.1.8. Lonza Group AG
14.1.9. Meissner Filtration Products, Inc.,
14.1.10. Merck KGaA
14.1.11. Rentschler Biopharma SE
14.1.12. Samsung BioLogics
14.1.13. Sartorius AG
14.1.14. Tornado Spectral Systems
14.1.15. Waters Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. UPSTREAM BIOPROCESSING MARKET RESEARCH PROCESS
FIGURE 2. UPSTREAM BIOPROCESSING MARKET SIZE, 2023 VS 2030
FIGURE 3. UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. UPSTREAM BIOPROCESSING MARKET DYNAMICS
FIGURE 7. UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 10. UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2023 VS 2030 (%)
FIGURE 12. UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2023 VS 2030 (%)
FIGURE 14. UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings